CDBIO disclosed the progress of its share repurchase, with a total repurchase amount of nearly 10.8 million yuan

Liaoning Chengda Biological Co., Ltd. announced the progress of its share repurchase through centralized bidding. The repurchase plan was first disclosed on June 19, 2025, with an implementation period until June 18, 2026, and an expected repurchase amount of 10 million to 20 million yuan, intended for employee stock ownership plans or equity incentives. As of September 30, 2025, the company had repurchased a total of 384,899 shares, accounting for approximately 0.092% of the total share capital, with a total payment amount of 10,789,216.56 yuan, and the actual repurchase price range was 27.20 yuan/share to 29.61 yuan/share. The company will continue to promote the repurchase in accordance with regulations and disclose information in a timely manner